Stay in touch
We'd love to keep in touch about news, events and how you can get involved. To hear from us, please sign up below.
We’re still trying to understand the impact of the COVID-19 pandemic on cancer services. So, it’s important to build a detailed picture of how patients have been affected.
Men can also get breast cancer. It’s rare, but around 370 are diagnosed with the disease every year in the UK. It’s important we the differences between breast cancer in men and women so we can find better ways to prevent and treat the disease.
Around 15% of breast cancer are classed as triple negative. This form of breast cancer currently has limited targeted treatments available. So, we need to find new and effective ways to treat people diagnosed with triple negative breast cancer.
In these blogs, we explore some of the biggest topics in breast cancer research. One of those topics is how the body’s biological clock is involved in breast cancer.
Scientists have discovered a new way to potentially improve the effectiveness of breast cancer treatment by targeting a variant of a common protein
To celebrate our research successes of the past year our research communications officer, Edd, picked out his favourite discoveries and explains why they are so important.
Researchers have uncovered the key to improving immunotherapy’s ability to stop breast cancer from spreading to the lungs.
Researchers have discovered new weaknesses in a special type of cell that supports cancer cells to grow and spread around the body.
Scientists, based at the Queen Mary University of London, have discovered a new mechanism that signals which Ductal Carcinoma in Situ (DCIS) tumours may progress to invasive breast cancer. This might help avoid unnecessary treatment for some women with DCIS in the future.